HomeALIVUS • NSE
add
Alivus Life Sciences Ltd
Previous close
₹958.40
Day range
₹933.30 - ₹968.40
Year range
₹850.00 - ₹1,251.00
Market cap
115.32B INR
Avg Volume
96.25K
P/E ratio
23.31
Dividend yield
0.53%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 6.02B | 2.25% |
Operating expense | 1.76B | 13.15% |
Net income | 1.22B | 9.02% |
Net profit margin | 20.19 | 6.60% |
Earnings per share | 9.88 | 8.81% |
EBITDA | 1.70B | 7.53% |
Effective tax rate | 25.43% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.49B | 81.98% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 28.17B | — |
Shares outstanding | 122.64M | — |
Price to book | 4.17 | — |
Return on assets | — | — |
Return on capital | 13.50% | — |
Cash Flow
Net change in cash
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 1.22B | 9.02% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2001
Website
Employees
2,203
